Filgrastim biosimilar (Fuji Pharmaceutical/Mochida/Gene Techno Science)

非格司亭生物类似药（Fuji Pharmaceutical/Mochida/Gene Techno Science）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Fuji Pharmaceutical/Mochida/Gene Techno Science)
Drug Alias Name重组人粒细胞刺激因子（Fuji Pharmaceutical/Mochida/Gene Techno Science）Filgrastim BS (Fuji Pharmaceutical/Mochida/Gene Techno Science)非格司亭生物仿制药（Fuji Pharmaceutical/Mochida/Gene Techno Science）Recombinant human granulocyte macrophage colony stimulating factor (Fuji Pharmaceutical/Mochida/Gene Techno Science)rhG-CSF (Fuji Pharmaceutical/Mochida/Gene Techno Science) +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2012/11/21
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMochda Pharmaceutical Co LtdFuji PharmaceuticalGene Techno Science
China Registration ClassN/A

Develop Information

Active CompaniesFuji Pharmaceutical
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A